MGF Dosage: How Much to Take, When & How

MGF Dosage: How Much to Take, When & How

Overview

Mechano Growth Factor (MGF) is a peptide derived from a splice variant of IGF-1, designed to activate muscle satellite cells and promote localized muscle repair and growth in response to mechanical stress. Unlike systemic IGF-1, MGF acts locally at the injection site, making it suitable for targeted muscle development and recovery support.

The standard dosing range for MGF is 100–200 mcg administered 2–3 times per week via injection, though individual protocols vary based on experience level, goals, and tolerance. This guide provides evidence-based dosing recommendations, administration methods, and cycling protocols to help you use MGF safely and effectively.

Cost: MGF typically ranges from $40–$120 per month depending on dosing frequency and supplier, making it relatively affordable compared to other peptide options.

Standard Dosing Protocol

The most commonly cited and research-supported dosing protocol for MGF is:

This protocol is derived from research contexts and anecdotal evidence from the performance community. The 100–200 mcg range represents the most practical "sweet spot" where efficacy appears to increase without proportionally increasing side effect risk.

Frequency rationale: Three injections weekly allows for consistent muscle satellite cell activation without the fatigue or localized swelling that can accompany daily dosing. Two injections weekly suits those prioritizing convenience over maximum response.

Dosing by Goal

MGF's effects vary slightly depending on your primary objective. Below are goal-specific dosing recommendations:

Muscle Hypertrophy (Primary Goal)

For maximum muscle growth potential:

• Dose: 150–200 mcg per injection
• Frequency: 3 times per week
• Total weekly: 450–600 mcg
• Injection timing: Post-workout (within 4 hours after training the target muscle)
• Cycle length: 10–12 weeks
• Rationale: Higher doses and increased frequency align with MGF's mechanism of satellite cell activation. Post-workout injection leverages the exercise-induced mechanical damage window when MGF responsiveness is elevated.

Injury Recovery / Accelerated Repair

For soft tissue repair following injury or joint stress:

• Dose: 100–150 mcg per injection
• Frequency: 2–3 times per week
• Total weekly: 200–450 mcg
• Injection site: Directly into or adjacent to the damaged tissue
• Cycle length: 6–8 weeks
• Rationale: Localized injection at the injury site maximizes MGF's paracrine effects on fibroblasts and tissue repair pathways without requiring systemic dosing.

General Recovery & Maintenance

For athletes recovering from high training volume:

• Dose: 100–150 mcg per injection
• Frequency: 2 times per week
• Total weekly: 200–300 mcg
• Injection timing: Non-training days or evening
• Cycle length: 8–10 weeks
• Rationale: Lower frequency and moderate doses provide recovery support with minimal side effects, suitable for ongoing use during heavy training phases.

Beginner / First-Time Protocol

For individuals new to MGF:

• Dose: 100 mcg per injection (start conservatively)
• Frequency: 2 times per week
• Total weekly: 200 mcg
• Cycle length: 6–8 weeks
• Rationale: Conservative dosing allows assessment of individual tolerance and response before escalating. Many beginners observe solid gains at this level.

How to Administer

Injection Route

MGF is administered exclusively by injection:

• Intramuscular (IM): Delivers MGF directly into muscle tissue; maximizes local satellite cell activation but carries slightly higher risk of injection site pain, redness, and swelling.
• Subcutaneous (SC): Injected into the fat layer beneath skin; less painful than IM, but may have slightly reduced localized efficacy due to slower diffusion into target muscle.

Recommendation: For muscle growth goals, intramuscular injection into the target muscle is preferred. For general recovery or injury sites (joints, ligaments), subcutaneous or IM injection adjacent to the tissue is appropriate.

Injection Technique

1. Preparation: Reconstitute lyophilized MGF powder with bacteriostatic water according to supplier instructions (typically 1–2 mL per vial).
2. Sterility: Use sterile, single-use needles (25–27 gauge for IM; 30 gauge for SC). Swab injection site with alcohol prep pad.
3. Volume per injection: 100–200 mcg MGF typically requires 0.5–1.0 mL of reconstituted solution, depending on concentration.
4. Injection depth: For IM, insert needle perpendicular to skin into the belly of the target muscle. For SC, insert at 45° angle into subcutaneous fat.
5. Rotation: Alternate injection sites weekly to minimize localized swelling and tissue damage. Avoid injecting the same site more than once per week.

Timing Considerations

• Post-workout injection (within 4 hours of resistance training) is optimal for muscle growth, as mechanical stress and elevated satellite cell sensitivity peak during this window.
• Non-training days: If dosing 3x weekly, inject 1–2 doses on rest days to distribute stimulus without overloading a single muscle group.
• Timing of day: Evening injections may reduce daytime localized swelling, but morning injections allow earlier post-workout administration on training days.

Cycling & Timing

Cycle Structure

MGF is typically used in finite cycles rather than continuously:

• "On" cycle: 8–12 weeks of consistent dosing
• "Off" cycle: 4–8 weeks of no MGF (allows receptor sensitivity to reset and endogenous IGF-1/MGF expression to normalize)
• Repeat: Cycle on → off → on as desired

Rationale: Continuous use risks receptor downregulation and potential accumulation of localized swelling. Cycling maintains responsiveness and minimizes side effects.

Sample Annual Protocol

• Weeks 1–10: MGF dosing (150 mcg, 3x weekly) during heavy hypertrophy phase
• Weeks 11–14: Off-cycle; focus on technique work and moderate intensity

• Weeks 15–24: Second MGF cycle with same or varied dosing
• Weeks 25–28: Off-cycle
• Repeat or adjust based on goals and response

Stacking Considerations

MGF is often used alongside other training and recovery modalities (resistance training, nutrition, sleep) but is rarely stacked with other peptides in established protocols. If combining with growth hormone or other IGF-1 variants, reduce MGF dose by 25–50% to minimize hypoglycemia risk and localized swelling.

Beginner vs Advanced Dosing

Beginner Protocol

• Weekly dose: 200 mcg (100 mcg × 2x weekly)
• Cycle: 8 weeks on, 6 weeks off
• Injection site: Single large muscle (quadriceps or glute)
• Monitoring: Track injection site response (pain, swelling, redness) and subjective recovery
• Expectation: Moderate gains in targeted muscle; improved recovery between sessions

Intermediate Protocol

• Weekly dose: 300–450 mcg (150 mcg × 2–3x weekly)
• Cycle: 10 weeks on, 6 weeks off
• Injection sites: Rotate between 2–3 muscle groups per week
• Monitoring: Weekly assessment of localized swelling; blood glucose monitoring if hypoglycemia symptoms appear
• Expectation: Noticeable hypertrophy in injected muscles; accelerated recovery from high-volume training

Advanced Protocol

• Weekly dose: 450–600 mcg (150–200 mcg × 3x weekly)
• Cycle: 10–12 weeks on, 8 weeks off
• Injection sites: Daily rotation across 4–6 muscle groups
• Monitoring: Weekly tracking of muscle thickness, localized swelling, blood glucose, and subjective wellbeing
• Expectation: Significant hypertrophy; marked acceleration in muscle repair; potential for asymmetric growth if not rotated carefully

Common Dosing Mistakes

1. Injecting the Same Site More Than Once Weekly

Mistake: Repeatedly injecting the same muscle without adequate spacing.

Consequence: Cumulative localized swelling, inflammation, fibrosis, and potential tissue damage.

Fix: Rotate injection sites—different muscle each injection, or wait 7+ days before re-injecting the same location.

2. Continuous Dosing Without Cycling

Mistake: Running MGF indefinitely without off-cycles.

Consequence: Receptor downregulation, diminished response, and sustained elevation of localized side effects.

Fix: Follow strict on/off cycling (8–12 weeks on, 4–8 weeks off).

3. Exceeding 200 mcg per Injection

Mistake: Progressively increasing dose assuming "more = better."

Consequence: Escalating localized swelling, injection site pain, and hypoglycemia risk without proportional efficacy gains.

Fix: Stay within the 100–200 mcg range; optimize frequency and cycling instead of dose escalation.

4. Post-Workout Injection Delays

Mistake: Injecting MGF hours after training when satellite cell sensitivity has already normalized.

Consequence: Reduced synergy between mechanical stimulus and MGF activation; suboptimal hypertrophy response.

Fix: Inject within 4 hours of completing resistance training on target muscles.

5. Inadequate Injection Site Rotation

Mistake: Injecting only one or two muscles throughout a cycle.

Consequence: Dramatic asymmetric growth; potential chronic inflammation in overused sites.

Fix: Distribute injections across at least 3–4 different muscles weekly, or vary single-muscle protocols across cycles.

6. Ignoring Early Hypoglycemia Signs

Mistake: Overlooking lightheadedness, tremors, or sudden fatigue following injection.

Consequence: Potential for dangerous hypoglycemic episodes, especially if fasted or combined with high insulin sensitivity.

Fix: Monitor blood glucose if symptoms appear; consume fast carbs if needed; reduce dose or frequency if pattern persists.

Summary Table

Key Takeaways

1. Start conservatively: Begin at 100 mcg, 2x weekly; assess tolerance before increasing.
2. Inject post-workout: Maximize response by injecting within 4 hours of resistance training.
3. Rotate injection sites: Alternate muscles weekly to prevent cumulative swelling and fibrosis.
4. Cycle consistently: Use 8–12 week on-cycles followed by 4–8 week off-cycles to maintain responsiveness.
5. Monitor side effects: Watch for injection site swelling, blood glucose fluctuations, and fatigue; adjust dose or frequency if needed.
6. Respect the dosing range: 100–200 mcg per injection is the established sweet spot; exceeding 200 mcg rarely improves outcomes and increases risk.

Disclaimer

This guide is educational content only and does not constitute medical advice. MGF is a research peptide with limited human clinical data; most evidence comes from animal studies and anecdotal reports. Before using MGF, consult a qualified healthcare provider, particularly if you have a history of diabetes, growth-factor-sensitive cancers, or are taking medications. Injecting any substance carries infection risk. Use only sterile equipment, follow aseptic technique, and monitor for adverse effects. Dosing recommendations in this guide reflect common practice in research and performance contexts but are not endorsed by medical authorities and may not be legal in your jurisdiction. Your individual response to MGF may differ from described protocols; adjust dosing based on personal tolerance and results.